Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Allows Outsourcers To Compound Hydroxychloroquine As COVID-19 Drives Demand
Pharmacies Say More Additions Needed
Mar 30 2020
•
By
Joanne S. Eglovitch
FDA Lets Outsourcers Bulk-Compound Malaria Drug That May Help Against COVID-19 • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance